Inmolecule Nanotech, S.A.
MLINA | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- ES0105908000
- LEI:
- 959800F0D3TQYVTXW034
- Country:
- Spain
- Address:
- N/A
- Website:
- https://www.inmolecule.com
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Inmolecule Nanotech, S.A. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Inmolecule Nanotech, S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inmolecule Nanotech, S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
Denmark
INIT
Denmark
INIT
CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.
United States of America
NOTV
United States of America
NOTV
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France
ALINT
France
ALINT
Developing curative CRISPR/Cas9 genome editing therapies for severe genetic disorders.
United States of America
NTLA
United States of America
NTLA
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America
IDCC
United States of America
IDCC
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea
287840
South Korea
287840
Develops drug delivery systems using microfluidics for chronic diseases and gene therapies.
South Korea
389470
South Korea
389470
Offers environmental consulting, R&D, and design for commercial eco-innovations.
Poland
IVE
Poland
IVE
Global provider of analytics, tech, and clinical research for life sciences and healthcare.
United States of America
IQV
United States of America
IQV
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL
Sweden
ISOFOL